Ganna Blazhenets • UCSF Profiles

Ganna Blazhenets, PhD

Title(s)	Assistant Researcher, Neurology
School	School of Medicine
Address	35 Medical Center Way San Francisco CA 94143
Pronouns	She/Her/Hers
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Deformation-based morphometry applied to FDG PET data reveals hippocampal atrophy in Alzheimer's disease. Sci Rep. 2024 08 28; 14(1):20030. Frings L, Blazhenets G, Brumberg J, Rau A, Urbach H, Meyer PT. PMID: 39198541; PMCID: PMC11358471.

View in: PubMed Mentions:
MRI-Based Assessment of Risk for Stroke in Moyamoya Angiopathy (MARS-MMA): An MRI-Based Scoring System for the Severity of Moyamoya Angiopathy. Diagnostics (Basel). 2024 Jul 05; 14(13). Zerweck L, Roder C, Blazhenets G, Martus P, Thurow J, Haas P, Estler A, Gohla G, Ruff C, Selo N, Würtemberger U, Khan N, Klose U, Ernemann U, Meyer PT, Hauser TK. PMID: 39001327; PMCID: PMC11241620.

View in: PubMed Mentions:
Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases. Ann Neurol. 2024 Sep; 96(3):539-550. Brumberg J, Blazhenets G, Bühler S, Fostitsch J, Rijntjes M, Ma Y, Eidelberg D, Weiller C, Jost WH, Frings L, Schröter N, Meyer PT. PMID: 38888141.

View in: PubMed Mentions:
Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation. Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jul 13; 133:111013. Miguel Telega L, Berti R, Blazhenets G, Domogalla LC, Steinacker N, Omrane MA, Meyer PT, Coenen VA, Eder AC, Döbrössy MD. PMID: 38636702.

View in: PubMed Mentions:
Disbalanced recruitment of crossed and uncrossed cerebello-thalamic pathways during deep brain stimulation is predictive of delayed therapy escape in essential tremor. Neuroimage Clin. 2024; 41:103576. Sajonz BEA, Frommer ML, Reisert M, Blazhenets G, Schröter N, Rau A, Prokop T, Reinacher PC, Rijntjes M, Urbach H, Meyer PT, Coenen VA. PMID: 38367597; PMCID: PMC10944187.

View in: PubMed Mentions:
[18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. J Nucl Med. 2023 12 01; 64(12):1980-1989. Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, Rosen HJ, Litvan I, Grossman M, Boeve B, Pantelyat A, Tartaglia MC, Irwin DJ, Dickerson BC, Baker SL, Boxer AL, Rabinovici GD, La Joie R. PMID: 37918868; PMCID: PMC10690126.

View in: PubMed Mentions: 1 Fields:
Nuc Nuclear Medicine
Translation:Humans
The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis. Alzheimers Res Ther. 2023 11 18; 15(1):202. Rau A, Schröter N, Blazhenets G, Maurer C, Urbach H, Meyer PT, Frings L. PMID: 37980531; PMCID: PMC10657637.

View in: PubMed Mentions:
Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions. Mov Disord Clin Pract. 2023 Jul; 10(7):1066-1073. Schröter N, Bormann T, Rijntjes M, Blazhenets G, Berti R, Sajonz BEA, Urbach H, Weiller C, Meyer PT, Rau A, Frings L. PMID: 37476309; PMCID: PMC10354622.

View in: PubMed Mentions:
[18F]PM-PBB3-PET Reveals Clinical and [18F]FDG-PET Mimics of 4-Repeat Tauopathy Caused by Creutzfeld-Jakob Disease. Mov Disord Clin Pract. 2023 Mar; 10(3):531-532. Schröter N, Blazhenets G, Meyer PT, Rijntjes M, Brumberg J. PMID: 36949786; PMCID: PMC10026304.

View in: PubMed Mentions:
More extensive hypometabolism and higher mortality risk in patients with right- than left-predominant neurodegeneration of the anterior temporal lobe. Alzheimers Res Ther. 2023 01 10; 15(1):11. Frings L, Blazhenets G, Binder R, Bormann T, Hellwig S, Meyer PT. PMID: 36627641; PMCID: PMC9830748.

View in: PubMed Mentions:
Evaluation of the cerebrovascular reactivity in patients with Moyamoya Angiopathy by use of breath-hold fMRI: investigation of voxel-wise hemodynamic delay correction in comparison to [15O]water PET. Neuroradiology. 2023 Mar; 65(3):539-550. Zerweck L, Hauser TK, Roder C, Blazhenets G, Khan N, Ernemann U, Meyer PT, Klose U. PMID: 36434312; PMCID: PMC9905170.

View in: PubMed Mentions:
Nigral glucose metabolism as a diagnostic marker of neurodegenerative parkinsonian syndromes. NPJ Parkinsons Dis. 2022 Sep 29; 8(1):123. Schröter N, Blazhenets G, Frings L, Jost WH, Weiller C, Rijntjes M, Meyer PT, Brumberg J. PMID: 36171206; PMCID: PMC9519554.

View in: PubMed Mentions:
Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. 2022 09 14; 145(9):3203-3213. Rau A, Schroeter N, Blazhenets G, Dressing A, Walter LI, Kellner E, Bormann T, Mast H, Wagner D, Urbach H, Weiller C, Meyer PT, Reisert M, Hosp JA. PMID: 35675908; PMCID: PMC9214163.

View in: PubMed Mentions:
68Ga-DOTA PET for Diagnosis of Spinal Cerebrospinal Fluid Leaks. J Nucl Med. 2023 03; 64(3):430-436. Evangelou P, Omrane MA, Thurow J, Mix M, Fung C, Lützen N, Blazhenets G, Urbach H, Beck J, Meyer PT. PMID: 35981896.

View in: PubMed Mentions:
Unravelling delayed therapy escape after thalamic deep brain stimulation for essential tremor? - Additional clinical and neuroimaging evidence. Neuroimage Clin. 2022; 36:103150. Sajonz BEA, Frommer ML, Walz ID, Reisert M, Maurer C, Rijntjes M, Piroth T, Schröter N, Jenkner C, Reinacher PC, Brumberg J, Meyer PT, Blazhenets G, Coenen VA. PMID: 35988341; PMCID: PMC9402391.

View in: PubMed Mentions:
Neural activity of the auditory cortex predicts speech recognition of patients with asymmetric hearing loss after cochlear implantation. Sci Rep. 2022 05 16; 12(1):8068. Speck I, Arndt S, Thurow J, Rau A, Aschendorff A, Meyer PT, Frings L, Blazhenets G. PMID: 35577877; PMCID: PMC9110403.

View in: PubMed Mentions:
A Neuroanatomy of Positive Affect Display - Subcortical Fiber Pathways Relevant for Initiation and Modulation of Smiling and Laughing. Front Behav Neurosci. 2022; 16:817554. Coenen VA, Sajonz BEA, Hurwitz TA, Böck M, Hosp JA, Reinacher PC, Urbach H, Blazhenets G, Meyer PT, Reisert M. PMID: 35464145; PMCID: PMC9022623.

View in: PubMed Mentions:
Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review. J Nucl Med. 2022 07; 63(7):971-980. Meyer PT, Hellwig S, Blazhenets G, Hosp JA. PMID: 35177424; PMCID: PMC9258567.

View in: PubMed Mentions:
Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome. J Nucl Med. 2022 07; 63(7):1058-1063. Dressing A, Bormann T, Blazhenets G, Schroeter N, Walter LI, Thurow J, August D, Hilger H, Stete K, Gerstacker K, Arndt S, Rau A, Urbach H, Rieg S, Wagner D, Weiller C, Meyer PT, Hosp JA. PMID: 34649946; PMCID: PMC9258569.

View in: PubMed Mentions:
Reply: From early limbic inflammation to long COVID sequelae. Brain. 2021 09 04; 144(8):e66. Meyer PT, Blazhenets G, Prinz M, Hosp JA. PMID: 34142114.

View in: PubMed Mentions:
Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain. 2021 05 07; 144(4):1263-1276. Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, Thurow J, Wagner D, Waller C, Niesen WD, Frings L, Urbach H, Prinz M, Weiller C, Schroeter N, Meyer PT. PMID: 33822001; PMCID: PMC8083602.

View in: PubMed Mentions:
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients. J Nucl Med. 2021 07 01; 62(7):910-915. Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, Weiller C, Meyer PT, Dressing A, Hosp JA. PMID: 33789937; PMCID: PMC8882885.

View in: PubMed Mentions:
Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab044. D'Amore F, Grinberg F, Mauler J, Galldiks N, Blazhenets G, Farrher E, Filss C, Stoffels G, Mottaghy FM, Lohmann P, Shah NJ, Langen KJ. PMID: 34013207; PMCID: PMC8117449.

View in: PubMed Mentions:
Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration. Neurology. 2021 03 02; 96(9):e1358-e1368. Blazhenets G, Frings L, Ma Y, Sörensen A, Eidelberg D, Wiltfang J, Meyer PT, Alzheimer's Disease Neuroimaging Initiative. PMID: 33408150; PMCID: PMC8589294.

View in: PubMed Mentions:
Brain activation patterns during visuomotor adaptation in motor experts and novices: An FDG PET study with unrestricted movements. J Neurosci Methods. 2021 02 15; 350:109061. Blazhenets G, Kurz A, Frings L, Leukel C, Meyer PT. PMID: 33370559.

View in: PubMed Mentions:
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy. NPJ Parkinsons Dis. 2020 Dec 11; 6(1):39. Brumberg J, Schröter N, Blazhenets G, Frings L, Volkmann J, Lapa C, Jost WH, Isaias IU, Meyer PT. PMID: 33311476; PMCID: PMC7733458.

View in: PubMed Mentions:
Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer's dementia: a comparison of methods. Alzheimers Res Ther. 2020 11 19; 12(1):155. Sörensen A, Blazhenets G, Schiller F, Meyer PT, Frings L, Alzheimer Disease Neuroimaging Initiative. PMID: 33213489; PMCID: PMC7678323.

View in: PubMed Mentions:
Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes. J Nucl Med. 2021 06 01; 62(6):855-860. Blazhenets G, Frings L, Sörensen A, Meyer PT, Alzheimer’s Disease Neuroimaging Initiative. PMID: 33097630; PMCID: PMC8729867.

View in: PubMed Mentions:
Tau Imaging in the 4-Repeat-Tauopathies Progressive Supranuclear Palsy and Corticobasal Syndrome: A 11C-Pyridinyl-Butadienyl-Benzothiazole 3 PET Pilot Study. Clin Nucl Med. 2020 Apr; 45(4):283-287. Schröter N, Blazhenets G, Frings L, Barkhausen C, Jost WH, Weiller C, Rijntjes M, Meyer PT. PMID: 32108694.

View in: PubMed Mentions:
Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia. J Nucl Med. 2020 04; 61(4):597-603. Blazhenets G, Ma Y, Sörensen A, Schiller F, Rücker G, Eidelberg D, Frings L, Meyer PT, Alzheimer Disease Neuroimaging Initiative. PMID: 31628215; PMCID: PMC7198373.

View in: PubMed Mentions:
18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss. J Nucl Med. 2020 03; 61(3):418-422. Speck I, Arndt S, Thurow J, Blazhenets G, Aschendorff A, Meyer PT, Frings L. PMID: 31481576.

View in: PubMed Mentions:
Imaging cardiac sympathetic innervation with MIBG: linear conversion of the heart-to-mediastinum ratio between different collimators. EJNMMI Phys. 2019 Jul 23; 6(1):12. Brumberg J, Blazhenets G, Schröter N, Frings L, Jost WH, Lapa C, Meyer PT. PMID: 31338697; PMCID: PMC6650508.

View in: PubMed Mentions:
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. Neuroimage Clin. 2019; 21:101637. Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L, Alzheimer's Disease Neuroimaging Initiative. PMID: 30553760; PMCID: PMC6411907.

View in: PubMed Mentions:
Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia. J Nucl Med. 2019 06; 60(6):837-843. Blazhenets G, Ma Y, Sörensen A, Rücker G, Schiller F, Eidelberg D, Frings L, Meyer PT, Alzheimer’s Disease Neuroimaging Initiative. PMID: 30389825.

View in: PubMed Mentions: